Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Non-Current Deferred Tax Liability (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Non-Current Deferred Tax Liability for 13 consecutive years, with $566000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $566000.0, compared with a TTM value of $566000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $566000.0, changed N/A over the prior year.
  • Non-Current Deferred Tax Liability was $566000.0 for Q4 2024 at Cross Country Healthcare, up from $237000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $9.5 million in Q2 2021 and bottomed at $190000.0 in Q4 2021.
  • Average Non-Current Deferred Tax Liability over 4 years is $4.6 million, with a median of $6.7 million recorded in 2020.
  • The sharpest move saw Non-Current Deferred Tax Liability soared 38.7% in 2021, then crashed 97.67% in 2022.
  • Year by year, Non-Current Deferred Tax Liability stood at $6.6 million in 2020, then crashed by 97.12% to $190000.0 in 2021, then increased by 24.74% to $237000.0 in 2022, then soared by 138.82% to $566000.0 in 2024.
  • Business Quant data shows Non-Current Deferred Tax Liability for CCRN at $566000.0 in Q4 2024, $237000.0 in Q3 2022, and $222000.0 in Q2 2022.